Medtronic

Current leadership (6)

• Geoff Martha Chairman & CEOIR-verified
• Mike Marinaro EVP & President, Surgical OUIR-verified
• Laura Mauri SVP, Chief Scientific/Medical/Regulatory OfficerIR-verified
• Mike Marinaro presidentSEC-verified
• Rajit Kamal executiveSEC-verified
• Dr. James Porter cmoSEC-verified

Board (1)

• Geoff Martha chair

Safety record

Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.

Incidents affecting Medtronic (5)

• Medtronic Hugo surgical robot earns FDA clearance for additional indication2026-07-01 · Regulatory action
• Medtronic Hugo RAS: failure to calibrate with the application program freezing or failing to launch (FDA MAUDE)2026-05-21 · Malfunction
• Medtronic Hugo RAS: unintended collision with the application program freezing or failing to launch (FDA MAUDE)2026-05-14 · Malfunction
• Medtronic Hugo RAS: bipolar grasper broke and dropped a resin insulator fragment into a patient (FDA MAUDE)2026-05-11 · Injury
• Medtronic Hugo RAS: robotic arm froze during undocking, leading to bleeding and open conversion (FDA MAUDE)2026-01-16 · Malfunction

Includes incidents linked directly to this company, to its models, or to deployments of its models or under its operation. Retracted incidents are excluded from this view but remain reachable at their canonical URLs.

Peer companies

• Intuitive Surgical2 models
• Johnson & Johnson2 models
• Stryker2 models
• Vantis2 models
• Asensus Surgical1 model
• Auris Health1 model

Supplied by (1)

Inbound supply edges feeding this company directly or via the models it owns. Same source bar as the outbound view (verified against at least two strong sources).

Financial state

Reporting basis

aggregator_estimate

Lifecycle stage

mature

Counterparty risk class

low

Each numeric field carries its own basis marker. Aggregators report a number; this surface preserves the source class so verification depth travels with the value.

Regulatory filings (1)

• K250725fda 510k · us_fdagranted2025-03-10reported

  Linked models: Hugo RAS

Acquisitions (4)

• acquired Intersect ENTfull acquisition2021-08-01
• acquired Digital Surgeryfull acquisition2020-02-13
• acquired Mazor Roboticsfull acquisition2018-09-20
• acquired Covidienfull acquisition2014-06-15

Sources (3)

1. https://news.medtronic.com/2025-12-03-Medtronic-announces-FDA-clearance-of-Hugo-TM-robotic-assisted-surgery-system-for-urologic-surgical-procedures ↗
2. https://news.medtronic.com/2021-10-11-Medtronic-Hugo-TM-Robotic-Assisted-Surgery-System-Receives-European-CE-Mark-Approval ↗
3. https://www.urologytimes.com/view/fda-grants-clearance-to-hugo-robotic-assisted-surgery-system-for-urologic-procedures ↗

Common questions

What is Medtronic?

Global medical-device company (NYSE: MDT; founded 1949) whose Hugo RAS is the late-market robotic-assisted-surgery challenger to da Vinci; CE-marked 2021, US FDA-cleared for urology Dec 2025.

Where is Medtronic based?

Medtronic is based in Dublin, Ireland.

When was Medtronic founded?

Medtronic was founded in 1949.

What does Medtronic make?

Medtronic has 1 robot model on the DEPLOY registry: Hugo RAS (Medtronic builds both physical robots and the AI that runs them).

Where does Medtronic operate robots?

Medtronic is a robot manufacturer and does not directly operate deployments on the DEPLOY registry. Its products are deployed by customer operators; see the company page for the verified deployment record.

Are there any incidents involving Medtronic?

5 active incidents involving Medtronic are on the DEPLOY registry. Each is a sourced, append-only record; retracted incidents are suppressed from this view.

Is Medtronic safe?

Medtronic has 5 active incidents on record in the DEPLOY registry. 5 incidents on record (2 serious, 2 moderate, 1 minor). Most recent: Jul 2026. Retracted incidents are excluded from this count.